TAEJOON PHARMACEUTICAL CO., LTD.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2024-03-07

Patent Grants:

Last grant date:

2026-03-17

Top Inventors for applications by TAEJOON PHARMACEUTICAL CO., LTD.

These are the the leading inventors for applications assigned to TAEJOON PHARMACEUTICAL CO., LTD.:

Joon Youb LEE 4 Seoul, South Korea
Dae Hun KIM 1 Suwon-si Gyeonggi-do, South Korea
Youn Jae SHIN 1 Suwon-si Gyeonggi-do, South Korea
Yong Jun KIM 1 Gyeonggio-do, South Korea

Hyun Won Seo 1 Jeonju-si, South Korea
Woo Young JANG 1 Suwon-Si, South Korea
Min Ji LEE 1 Gyeonggi-do, South Korea
Hyun Won SEO 1 Jeonju-si Jeollabuk-do, South Korea

Youn Jae SHIN 1 Gyeonggi-do, South Korea
Yiseul SONG 1 Suwon-Si, South Korea
Dae Hun Kim 1 Suwon-Si, South Korea
Wan GU 1 Gyeonggi-do, South Korea

Woo Young JANG 1 Gyeonggio-do, South Korea
Youn Jae Shin 1 Suwon-si, South Korea
Young Un KIM 1 Gyeonggio-do, South Korea

Recent patent applications by TAEJOON PHARMACEUTICAL CO., LTD.

TAEJOON PHARMACEUTICAL CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-03-07

US20240075060A1

Human necessities

ORAL SOLID FORMULATION FOR COLON CLEANSING

#2 | 2024-02-08 ✅ Patent 12,576,126 granted on 2026-03-17

US20240041974A1

Human necessities

NANOEMULSION OPHTHALMIC COMPOSITION COMPRISING CYCLOSPORINE AND MENTHOL, AND PREPARATION METHOD THEREOF

#3 | 2021-02-25 ✅ Patent 11,510,884 granted on 2022-11-29

US20210052510A1

Human necessities

Bowel cleansing composition

#4 | 2019-10-10 ✅ Patent 10,905,695 granted on 2021-02-02

US20190307768A1

Human necessities

Ophthalmic composition for lowering intraocular pressure

Also check out TAEJOON PHARMACEUTICAL CO., LTD.'s (Seoul, South Korea) applicant profile with 5 patent applications submitted.

AssigneeID:

307709 ⎘